NCT04784650

Brief Summary

Diabetes mellitus is one of the main causes of chronic kidney disease (CKD) and an increased risk of foot complications is seen in patients suffering from both DM and CKD. CKD and DM patients share a trilogy of risk factors that contribute to the development of foot ulcers. This trilogy consists of peripheral arterial disease (PAD), neuropathy and an increased susceptibility to infection with an impaired wound healing. Additionally, almost one quarter of adults with CKD have to cope with depression. The aim of our study is to determine the prevalence and types of foot problems in a pre-dialysis population, consisting of both DM and non-DM patients. If possible, risk factors will be determined. The detrimental effects of poor kidney function and foot problems on the quality of life and the general health status will be analyzed. A higher prevalence of PAD, peripheral neuropathy and DM are expected in patients with foot problems compared to those without.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 31, 2021

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

March 1, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 5, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2021

Completed
Last Updated

December 29, 2023

Status Verified

December 1, 2023

Enrollment Period

3 months

First QC Date

March 1, 2021

Last Update Submit

December 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of foot problems (no = 0, yes = 1)

    To describe the prevalence and type of foot complaints/problems in a pre-dialysis population during foot assessment

    at baseline

Secondary Outcomes (3)

  • European Foot and Ankle Society (EFAS) questionnaire

    at baseline

  • Kidney Disease Quality of Life Short Form (KDQOL-SF) questionnaire

    at baseline

  • Indication of peripheral arterial disease (PAD)

    at baseline

Study Arms (1)

Pre-dialysis population

OTHER

Pre-dialysis population, consisting both Diabetes Mellitus (DM) and non-DM patients

Other: Pre-dialysis population

Interventions

Pre-dialysis population, consisting of both Diabetes Mellitus (DM) and non-DM patients

Pre-dialysis population

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects must counsel the pre-dialysis outpatient ward at UZ Leuven
  • Minimum age of 18 years old
  • Signed informed consent

You may not qualify if:

  • Unable to understand Dutch
  • Unable to fill in questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

Location

MeSH Terms

Conditions

Foot UlcerDiabetes MellitusRenal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Foot DiseasesSkin DiseasesSkin and Connective Tissue DiseasesLeg UlcerSkin UlcerGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Giovanni Matricali

    Universitaire Ziekenhuizen KU Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2021

First Posted

March 5, 2021

Study Start

January 31, 2021

Primary Completion

April 24, 2021

Study Completion

April 24, 2021

Last Updated

December 29, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations